These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32854330)

  • 1. A Fluorescent Assay to Search for Inhibitors of HIV-1 Integrase Interactions with Human Ku70 Protein, and Its Application for Characterization of Oligonucleotide Inhibitors.
    Galkin S; Rozina A; Zalevsky A; Gottikh M; Anisenko A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting.
    Anisenko AN; Knyazhanskaya ES; Zalevsky AO; Agapkina JY; Sizov AI; Zatsepin TS; Gottikh MB
    Sci Rep; 2017 Jul; 7(1):5649. PubMed ID: 28717247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of HIV-1 integrase activity by single-stranded oligonucleotides and their conjugates with eosin.
    Korolev S; Knyazhanskaya E; Anisenko A; Tashlitskii V; Zatsepin TS; Gottikh M; Agapkina J
    Nucleosides Nucleotides Nucleic Acids; 2011; 30(7-8):651-66. PubMed ID: 21888554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex of HIV-1 Integrase with Cellular Ku Protein: Interaction Interface and Search for Inhibitors.
    Ilgova E; Galkin S; Khrenova M; Serebryakova M; Gottikh M; Anisenko A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction.
    Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R
    Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
    Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
    PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides.
    Jing N; Marchand C; Guan Y; Liu J; Pallansch L; Lackman-Smith C; De Clercq E; Pommier Y
    DNA Cell Biol; 2001 Aug; 20(8):499-508. PubMed ID: 11560782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase.
    Vandegraaff N; Kumar R; Hocking H; Burke TR; Mills J; Rhodes D; Burrell CJ; Li P
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2510-6. PubMed ID: 11502522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-1 integrase inhibition by modified oligonucleotides: optimization of the inhibitor structure].
    Prikazchikova TA; Volkov EM; Zubin EM; Romanova EA; Gottikh MB
    Mol Biol (Mosk); 2007; 41(1):130-8. PubMed ID: 17380900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
    Bhatt H; Patel P; Pannecouque C
    Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a hexasubstituted benzene scaffold in the development of multivalent HIV-1 integrase inhibitors.
    Tupchiangmai W; Choksakulporn S; Tewtrakul S; Pianwanit S; Sritana-anant Y
    Chem Pharm Bull (Tokyo); 2014; 62(8):754-63. PubMed ID: 25087627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
    George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
    Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.
    Esposito F; Tintori C; Martini R; Christ F; Debyser Z; Ferrarese R; Cabiddu G; Corona A; Ceresola ER; Calcaterra A; Iovine V; Botta B; Clementi M; Canducci F; Botta M; Tramontano E
    Chembiochem; 2015 Nov; 16(17):2507-12. PubMed ID: 26360521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity.
    Mesplède T; Osman N; Wares M; Quashie PK; Hassounah S; Anstett K; Han Y; Singhroy DN; Wainberg MA
    J Antimicrob Chemother; 2014 Oct; 69(10):2733-40. PubMed ID: 24917583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.